Naturally occurring terphenyls and related compounds such as terferol and its corresponding quinone and phlebiarubrone were synthesized from 2,5-diphenyl-1,4-benzoquinone. According to the proposed biosynthetic pathway, chemical conversion of phlebiarubrone to ustalic acid, a toxic compound isolated from the poisonous mushroom, Tricholoma ustale, was examined to find a low-yield conversion to the ustalic acid dimethyl ester.
Terphenyl is a common structural motif found in various natural products, largely isolated from microorganisms and mushrooms. 1) Because of the diverse structure as well as its wide variety of biological activities, including antioxidative, neurotoxicity, immunosuppressive, plant growth regulation, antibacterial and insecticidal, these natural products have attracted great attention.
2) Although many highly oxygenated terphenyl compounds with hydroxyl groups in the aromatic rings have been isolated, relatively simple terphenyl compounds also exhibit interesting biological activities. Terferol (1) isolated from Streptomyces showdoensis SANK65080 is an inhibitor of cyclic AMP-and cyclic GMP-phosphodiesterase (Fig. 1) . 3, 4) ; * Recently, corresponding o-quinone 2 was isolated from a Phoma sp. as an inhibitor of parasite cyclic GMP-dependent protein kinase. 6) Ustalic acid (3) was isolated as a toxic principle of mushroom poisoning by Tricholoma ustale (Kakishimeji in Japanese), and inhibited Na þ , K þ -ATPase.
7)
The unique structure of 3 is assumed to be biosynthesized by oxidative cleavage of phlebiarubrone (4), a well-known red pigment, originally isolated from cultured mycelia of the toadstool, Phlebia strigosozonata. 8) We have been interested in the chemical relationship among these structurally unique natural products with significant biological activities. We describe herein an efficient and expeditious synthetic route for the simple terphenyl and related compound, ** and attempts at the chemical conversion of phlebiarubrone to ustalic acid according to the biosynthetic hypothesis.
7)

Results and Discussion
Key compounds 7 and 10 for the synthetic studies were synthesized from commercially available 2,5-diphenyl-1,4-benzoquinone (5) according to modified procedures of Nozaki and co-workers. 10) Thiele-Winter acetoxylation of 2,5-diphenyl-1,4-benzoquinone (5) with perchloric acid in acetic anhydride gave triacetate 6 (Scheme 1).
11) Upon treatment of product 6 with K 2 CO 3 in methanol, the acetyl group at the 5 0 position was selectively removed to give 7 in a 90% yield. Phenol 7 was methylated with CH 3 I in the presence of K 2 CO 3 , and the remaining two acetates of 8 were hydrolyzed under acidic conditions to afford terferol (1) in a good yield. On the other hand, oxidation of 1 with y To whom correspondence should be addressed. Fax: +81-52-789-4111; E-mail: nisikawa@agr.nagoya-u.ac.jp
Fetizon's reagent 12) gave corresponding o-quinone 2 in a high yield. However, the NMR spectra of synthetic 2 were not identical to those of the literature. 6); *** Phlebiarubrone (4) was synthesized from 7 as shown in Scheme 2. Protection of phenol 7 with a benzyl group under conventional conditions gave 9, in which two acetates were hydrolyzed with hydrochloric acid in dioxane to give catechol 10. In the transformation of 10 to methylene ketal 11 with diiodomethane in the presence of K 2 CO 3 , we found that dissolved oxygen caused the decomposition of substrate 10 and product 11 during the reaction, resulting in low yields (up to ca. 30%). Thus, when the reaction was conducted under oxygen-free conditions (see the experimental section), ketal 11 could be obtained reproducibly in a good overall yield from 9. Deprotection of the benzyl group under hydrogenolytic conditions was followed by oxidation with Fremy's salt 13) to afford phlebiarubrone (4) in a high yield. NMR data for the synthetic material were good agreement with those of the literature. 14) Since the scalable synthesis of phlebiarubrone had been established, chemical conversion of phlebiarubrone (4) to ustalic acid (3) was next examined. Many reactions for the oxidative cleavage of o-quinones or their o-dihydroquinones (catechols) to dicarboxylic acids have been reported: Baeyer-Villiger type of oxidation with peracids, 15, 16) oxidation with potassium superoxide, 17) oxygen with copper-pyridine complex, 18) potassium permanganate 19) and lead tetraacetate, 20) and a photo-induced reaction. 21) However, the dihydroquinone obtained by reduction of 4 could not be isolated because of its extreme instability. Instead, hydroquinone monoacetate 13 was prepared by a brief treatment of 4 with Zn-Cu in acetic anhydride (Scheme 3), while the prolonged reaction time gave the corresponding diacetate. 8) We then examined the conversion of 4 and 13 to ustalic acid. Many experiments under the abovementioned conditions led us to find that phlebiarubrone was treated with a large excess of lead tetraacetate in methanol and toluene to give ustalic acid dimethyl ester 14 in a poor yield. Unfortunately, all attempts to improve this yield failed. Thus, it has been the sole condition for the transformation, while all the other conditions have never yielded ustalic acid (3) and its ester or anhydride. Spectroscopic data for synthetic 14 were identical to those derived from the methylation of natural ustalic acid with TMS-diazomethane. 22) Because of the limited amount of dimethyl ester 14, hydrolysis of the ester has not yet been examined.
In conclusion, we developed a new practical route for the synthesis of terferol, its o-quinone, and phlebiarubrone from the same starting material. Chemical conversion of phlebiarubrone (4) to ustalic acid derivative 14 was achieved for the first time by oxidative cleavage with lead tetraacetate, although the yield was poor.
Experimental
Melting point (Mp) data were recorded by a Yanaco MP-S3 melting point apparatus and are not corrected. Infrared spectra (IR) were recorded by a JASCO FT/IR-8300 spectrophotometer and are reported in wave number (cm À1 ). Proton nuclear magnetic resonance C for 2 h, the mixture was cooled to room temperature, and then poured into ice-cold water (100 ml). The mixture was extracted with EtOAc (50 ml Â 4). The combined organic layers were dried over anhydrous Na 2 SO 4 and filtered. The filtrate was concentrated under reduced pressure to give a crude product which was crystallized from MeOH to give triacetate 6 (5.81 g, 73%) as colorless crystals. C, (lit. 11) 
To a stirred solution of diacetate 7 (1.30 g, 3.59 mmol) in DMF (40 ml) were added CH 3 I (1.0 ml, 16 mmol) and K 2 CO 3 (700 mg, 5.07 mmol) at 0 C. The resulting purple mixture was stirred at room temperature for 2 h, cooled back to 0 C, and then diluted with Et 2 O (40 ml). The mixture was successively washed with a sat. aqueous NH 4 Cl solution, sat. aqueous NaHCO 3 solution (50 ml), and brine (50 ml). The organic layer was dried over anhydrous Na 2 SO 4 , filtered through a cotton pad, and concentrated in vacuo. 23) 291.1100; found, 291.1004.
To a stirred solution of 7 (11.2 g, 31.0 mmol) in DMF (343 ml) were added BnBr (7.3 ml, 62 mmol) and K 2 CO 3 (6.00 g, 43.4 mmol). The reaction mixture was successively stirred at room temperature for 5 h, and then diluted with EtOAc. The mixture was washed with water (Â2), a sat. aqueous NaHCO 3 solution (Â1) and brine (Â1), dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure. The resulting residue was washed with hexane to afford 9 as a white solid (11.8 g, 84% 
To a stirred suspension of 9 (3.02 g, 6.68 mmol) in 1,4-dioxane (55 ml) was added 3N HCl (55 ml) at rt. After being stirred at 80 C for 24 h, the reaction mixture was extracted with Et 2 O (Â3). The combined organic layers were washed with brine (Â2), dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure. The resulting residue was washed with hexane to afford 10 (2.40 g), which was used in the next reaction without further purification. An analytical sample was prepared by recrystallization from EtOAchexane. Mp 132. 5 
Into a flask were placed catechol 10 (2.00 g, 5.43 mmol), K 2 CO 3 (3.20 g, 23.1 mmol), DMF (60 ml) and CH 2 I 2 (1.2 ml, 15 mmol), the whole mixture being degassed through freeze-thaw cycles. The mixture was stirred for 1 h at 60 C, cooled to room temperature, and then diluted with Et 2 O. The mixture was washed with a sat. aqueous NH 4 Cl solution, and the aqueous layer was extracted with Et 2 O (Â3). The combined organic extract was successively washed with water, a sat. aqueous Na 2 SO 3 solution and brine. The organic layer was dried over anhydrous Na 2 SO 4 , filtered through a cotton pad, and concentrated in vacuo. (12) . Compound 11 (1.50 g, 4.00 mmol), EtOAc (80 ml), EtOH (40 ml), and 10% Pd/C (1.5 g, wet water content = 55 wt %, purchased from Kawaken Fine Chemicals Co., Ltd.) were placed in a round-shaped flask (200 ml) connected to a three-way cock. The atmosphere in the reaction vessel was replaced with nitrogen, and then filled with hydrogen (1 atm). After stirring for 5 h at room temperature, the catalyst was filtered off through a pad of Hyflo Super-Cel Ò (rinsed with EtOAc). The combined filtrate was concentrated under reduced pressure to afford 12 (1.10 g), which was used in the next reaction without further purification. Ustalic acid dimethyl ester (14) . Into a flask was placed phlebiarubrone 4 (40.0 mg, 0132 mmol) and Pb(OAc) 4 (1.16 g, 2.62 mmol). The reaction vessel was evacuated and then filled with nitrogen. Toluene (3 ml) and MeOH (2 ml) were added, the mixture was stirred at room temperature for 41 h, and then filtered through a pad of Hyflo Super-Cel Ò . The filtrate was diluted with water, and ethylene glycol (a few drops) was added. The resulting solution was extracted with Et 2 O. The combined organic layers were successively washed with water (Â1), a sat. aqueous NaHCO 3 solution (Â1), and water (Â1), dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was purified by column chromatography (5 g of silica gel, EtOAc/hexane = 1:5) followed by preparative TLC (EtOAc/hexane = 1:2, then CH 2 Cl 2 ) to afford ustalic acid dimethyl ester 14 (2.5 mg, 5 
